301 related articles for article (PubMed ID: 12023317)
1. Activity of a newly identified serine protease in CNS demyelination.
Scarisbrick IA; Blaber SI; Lucchinetti CF; Genain CP; Blaber M; Rodriguez M
Brain; 2002 Jun; 125(Pt 6):1283-96. PubMed ID: 12023317
[TBL] [Abstract][Full Text] [Related]
2. The response of NG2-expressing oligodendrocyte progenitors to demyelination in MOG-EAE and MS.
Reynolds R; Dawson M; Papadopoulos D; Polito A; Di Bello IC; Pham-Dinh D; Levine J
J Neurocytol; 2002; 31(6-7):523-36. PubMed ID: 14501221
[TBL] [Abstract][Full Text] [Related]
3. Oligodendrocyte survival, loss and birth in lesions of chronic-stage multiple sclerosis.
Wolswijk G
Brain; 2000 Jan; 123 ( Pt 1)():105-15. PubMed ID: 10611125
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of protease M/neurosin in oligodendrocytes and their progenitors in an animal model of multiple sclerosis.
Terayama R; Bando Y; Jiang YP; Mitrovic B; Yoshida S
Neurosci Lett; 2005 Jul 1-8; 382(1-2):82-7. PubMed ID: 15911126
[TBL] [Abstract][Full Text] [Related]
5. Astrogliosis in EAE spinal cord: derivation from radial glia, and relationships to oligodendroglia.
Bannerman P; Hahn A; Soulika A; Gallo V; Pleasure D
Glia; 2007 Jan; 55(1):57-64. PubMed ID: 17009237
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibody to Theiler's murine encephalomyelitis virus defines a determinant on myelin and oligodendrocytes, and augments demyelination in experimental allergic encephalomyelitis.
Yamada M; Zurbriggen A; Fujinami RS
J Exp Med; 1990 Jun; 171(6):1893-907. PubMed ID: 1693653
[TBL] [Abstract][Full Text] [Related]
7. Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE.
Eltayeb S; Berg AL; Lassmann H; Wallström E; Nilsson M; Olsson T; Ericsson-Dahlstrand A; Sunnemark D
J Neuroinflammation; 2007 May; 4():14. PubMed ID: 17484785
[TBL] [Abstract][Full Text] [Related]
8. Pathogenic myelin oligodendrocyte glycoprotein antibodies recognize glycosylated epitopes and perturb oligodendrocyte physiology.
Marta CB; Oliver AR; Sweet RA; Pfeiffer SE; Ruddle NH
Proc Natl Acad Sci U S A; 2005 Sep; 102(39):13992-7. PubMed ID: 16172404
[TBL] [Abstract][Full Text] [Related]
9. Enzymatic properties of rat myelencephalon-specific protease.
Blaber SI; Scarisbrick IA; Bernett MJ; Dhanarajan P; Seavy MA; Jin Y; Schwartz MA; Rodriguez M; Blaber M
Biochemistry; 2002 Jan; 41(4):1165-73. PubMed ID: 11802715
[TBL] [Abstract][Full Text] [Related]
10. Inflammation promotes survival and migration of the CG4 oligodendrocyte progenitors transplanted in the spinal cord of both inflammatory and demyelinated EAE rats.
Tourbah A; Linnington C; Bachelin C; Avellana-Adalid V; Wekerle H; Baron-Van Evercooren A
J Neurosci Res; 1997 Dec; 50(5):853-61. PubMed ID: 9418972
[TBL] [Abstract][Full Text] [Related]
11. Involvement of neuropsin in the pathogenesis of experimental autoimmune encephalomyelitis.
Terayama R; Bando Y; Yamada M; Yoshida S
Glia; 2005 Nov; 52(2):108-18. PubMed ID: 15920728
[TBL] [Abstract][Full Text] [Related]
12. Novel role for SLPI in MOG-induced EAE revealed by spinal cord expression analysis.
Mueller AM; Pedré X; Stempfl T; Kleiter I; Couillard-Despres S; Aigner L; Giegerich G; Steinbrecher A
J Neuroinflammation; 2008 May; 5():20. PubMed ID: 18501024
[TBL] [Abstract][Full Text] [Related]
13. Lentivirus-mediated estrogen receptor α overexpression in the central nervous system ameliorates experimental autoimmune encephalomyelitis in mice.
Hu X; Qin X
Int J Mol Med; 2013 May; 31(5):1209-21. PubMed ID: 23525227
[TBL] [Abstract][Full Text] [Related]
14. Cathepsin C modulates myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis.
Durose WW; Shimizu T; Li J; Abe M; Sakimura K; Chetsawang B; Tanaka KF; Suzumura A; Tohyama K; Ikenaka K
J Neurochem; 2019 Feb; 148(3):413-425. PubMed ID: 30152001
[TBL] [Abstract][Full Text] [Related]
15. The remyelinating potential and in vitro differentiation of MOG-expressing oligodendrocyte precursors isolated from the adult rat CNS.
Crang AJ; Gilson JM; Li WW; Blakemore WF
Eur J Neurosci; 2004 Sep; 20(6):1445-60. PubMed ID: 15355312
[TBL] [Abstract][Full Text] [Related]
16. The potential for oligodendrocyte proliferation during demyelinating disease.
Prayoonwiwat N; Rodriguez M
J Neuropathol Exp Neurol; 1993 Jan; 52(1):55-63. PubMed ID: 8381162
[TBL] [Abstract][Full Text] [Related]
17. Activating transcription factor 6α deficiency exacerbates oligodendrocyte death and myelin damage in immune-mediated demyelinating diseases.
Stone S; Wu S; Jamison S; Durose W; Pallais JP; Lin W
Glia; 2018 Jul; 66(7):1331-1345. PubMed ID: 29436030
[TBL] [Abstract][Full Text] [Related]
18. TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination.
Liu J; Marino MW; Wong G; Grail D; Dunn A; Bettadapura J; Slavin AJ; Old L; Bernard CC
Nat Med; 1998 Jan; 4(1):78-83. PubMed ID: 9427610
[TBL] [Abstract][Full Text] [Related]
19. The distribution of inflammatory demyelinated lesions in the central nervous system of rats with antibody-augmented demyelinating experimental allergic encephalomyelitis.
Meeson AP; Piddlesden S; Morgan BP; Reynolds R
Exp Neurol; 1994 Oct; 129(2):299-310. PubMed ID: 7525334
[TBL] [Abstract][Full Text] [Related]
20. Treatment with a recombinant human IgM that recognizes PSA-NCAM preserves brain pathology in MOG-induced experimental autoimmune encephalomyelitis.
Lemus HN; Warrington AE; Denic A; Wootla B; Rodriguez M
Hum Antibodies; 2017; 25(3-4):121-129. PubMed ID: 28269761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
